Search Results for " Alogliptin "
Alogliptin Related Products
Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus. Alogliptin and other gliptins are commonly used in combination with metformin in people whose diabetes cannot adequately be controlled with metformin alone. it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose-lowering activity.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Alogliptin, pharmacopeial and non-pharmacopeial Alogliptin impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Alogliptin impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Alogliptin-related products are thoroughly characterized. Alogliptin products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.